Photo via Toronto Star

Z Optics Presents Six-Month Clinical Results for the Z+ Virtual Aperture IOL at ESCRS 2026

Read the original at Toronto Star ↗
Cite

Z Optics Presents Six-Month Clinical Results for the Z+ Virtual Aperture IOL at ESCRS 2026. (2026, September 21). Toronto Star. https://www.thestar.com/globenewswire/z-optics-presents-six-month-clinical-results-for-the-z-virtual-aperture-iol-at-escrs/article_ed3e1cb5-b339-555e-b79f-f85beaed97ba.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-21 · by GlobeNewswire, Inc.

Quick Summary

Z Optics Inc., a medical device company, presented six-month clinical results for its Z+ Virtual Aperture intraocular lens (IOL) at the ESCRS conference in London from September 11 to 15, 2026. Dr. Francisco Sánchez León of Novavision Laser Center in Naucalpan, Mexico, led a study involving 43 patients with 86 eyes, where 38 eyes received the third-generation Z+ IOL. The results showed that all eyes with the third-generation lens achieved uncorrected distance vision of at least 20/32 (mean 20/24) and near vision of at least 20/32 (mean 20/26), with minimal reduction in acuity under low light conditions.
Written by AI on 2026-09-21, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Z Optics Inc., a medical device company based in Reno, Nevada, announced the six-month clinical results of its Z+ Virtual Aperture intraocular lens (IOL) at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) held from September 11 to 15, 2026, in London. Dr. Francisco Sánchez León of Novavision Laser Center in Naucalpan, Mexico, presented a single-center study involving 43 patients (86 eyes) who received the Z+ IOL in both eyes, with 38 eyes implanted with the latest third-generation design. The results showed that all 38 eyes achieved uncorrected distance vision of 20/32 or better, averaging 20/24, and 92 percent achieved uncorrected near vision of 20/32 or better, averaging 20/26. Even in low light conditions (mesopic), the mean uncorrected acuity was only slightly reduced at 20/25 for distance and 20/28 for near vision.

Written for “Z Optics IOL Clinical Results” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Z Optics IOL Clinical Results
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
5
sentences that state something as happening or true
Uncertain
0%
0 of 5 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-21 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 11255 article(s) · 28 correction(s) detected
Running correction rate · 28 correction(s)
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

ESCRS Nev. RENO Z Optics Inc. the European Society of Cataract and Refractive Surgeons

Subjects

ESCRS ORG · 1× Francisco Sánchez León PERSON · 1× London GPE · 1× Mexico GPE · 1× Naucalpan GPE · 1× Nev. GPE · 1× Novavision Laser Center ORG · 1× RENO GPE · 1× Z Optics Inc. ORG · 1× the European Society of Cataract and Refractive Surgeons ORG · 1×

Narrative

Z Optics Inc., a medical device company developing the Z+ Virtual Aperture intraocular lens (IOL) for cataract surgery patients, today announced that six-month clinical results for the lens were presented at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held from 11 to 15 September 2026 in London.
framing: assertive · carried by 1 article(s) · first seen 2026-09-21

Claims (5 extracted, 0 hedged)

Z Optics Inc., a medical device company developing the Z+ Virtual Aperture intraocular lens (IOL) for cataract surgery patients, today announced that six-month clinical results for the lens were presented at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held from 11 to 15 September 2026 in London. asserted
results → develop → London
The presentation, “Safety and Effectiveness of a Total Depth-of-Focus Intraocular Lens with a Virtual Aperture Optic”, was delivered by Dr. Francisco Sánchez León of Novavision Laser Center in Naucalpan, Mexico, lead investigator of the study. asserted
presentation → deliver → study
The single-center study enrolled 43 patients (86 eyes) who received the Z+ IOL in both eyes, including 38 eyes implanted with the latest, third-generation design. asserted
who → enrol → design
Six months after surgery, 100 percent of eyes with the third-generation lens achieved uncorrected distance vision of 20/32 or better in daylight conditions, with a mean of 20/24, and 92 percent achieved uncorrected near vision of 20/32 or better, with a mean of 20/26. asserted
percent → achieve → 20/26
Vision was barely reduced in low light: under mesopic conditions, mean uncorrected acuity was 20/25 at distance and 20/28 at near. asserted
acuity → reduce → near
💬Give feedback
🕘History 🎫Support